Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/26596
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Schulman S | - |
dc.contributor.author | Harenberg J | - |
dc.date.accessioned | 2021-06-15T16:01:33Z | - |
dc.date.available | 2021-06-15T16:01:33Z | - |
dc.date.issued | 2021-04-08 | - |
dc.identifier.issn | 0340-6245 | - |
dc.identifier.issn | 2567-689X | - |
dc.identifier.uri | http://hdl.handle.net/11375/26596 | - |
dc.description.abstract | <jats:p>No Abstract</jats:p> | - |
dc.publisher | Georg Thieme Verlag KG | - |
dc.title | Anticoagulant treatment of COVID-19 as early as possible – Sulodexide and perspectives | - |
dc.type | Article | - |
dc.date.updated | 2021-06-15T16:01:32Z | - |
dc.identifier.doi | https://doi.org/10.1055/a-1477-3569 | - |
Appears in Collections: | Faculty Publications (via McMaster Experts) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Anticoagulant treatment of COVID-19 as early as possible – Sulodexide and perspectives.pdf | Published version | 1.28 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.